Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
Takayuki Yoshino(University of Tsukuba), Jean‐Yves Douillard(Integrated Oncology (United States)), Josep Tabernero(Deaconess Hospital), George Pentheroudakis(Hellenic Cooperative Oncology Group), Joong Bae Ahn(Yonsei University), Atsushi Ohtsu(National Cancer Center Hospital East), S. Zhang(Zhejiang University), Kentaro Yamazaki(Shizuoka Cancer Center), Fortunato Ciardiello(University of Campania "Luigi Vanvitelli"), Dirk Arnold(Asklepios Klinik Altona), Axel Grothey(Campbell Clinic), Dawn Q. Chong(National Cancer Centre Singapore), Scott Kopetz(The University of Texas MD Anderson Cancer Center), Hiroya Taniguchi(National Cancer Center Hospital East), Kei Muro(Aichi Cancer Center), Liqun Chen(National Health Research Institutes), Hiromichi Ebi(Aichi Cancer Center), Hironobu Minami(Kobe University), Takako Eguchi-Nakajima(St. Marianna University School of Medicine), Andrés Cervantes(INCLIVA Health Research Institute), Tae‐Woo Kim(The Catholic University of Korea Incheon St. Mary's Hospital), Rui‐Hua Xu(Sun Yat-sen University), M.Y. Mastura(Hospital Kuala Lumpur), Iain Tan(National Cancer Centre Singapore), Kun‐Huei Yeh(National Taiwan University Hospital), Muhammad Ismail(Cork University Hospital)
Cited by 591
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k